Head to Head Contrast: Strata Skin Sciences (NASDAQ:SSKN) and Unilife Corp (UNIS)

Strata Skin Sciences (NASDAQ: SSKN) and Unilife Corp (NASDAQ:UNIS) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, risk, earnings and dividends.

Risk and Volatility

Strata Skin Sciences has a beta of 0.47, meaning that its share price is 53% less volatile than the S&P 500. Comparatively, Unilife Corp has a beta of -0.92, meaning that its share price is 192% less volatile than the S&P 500.

Earnings and Valuation

This table compares Strata Skin Sciences and Unilife Corp’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Strata Skin Sciences $32.37 million 0.11 $5.87 million ($2.70) -0.57
Unilife Corp N/A N/A N/A N/A N/A

Strata Skin Sciences has higher revenue and earnings than Unilife Corp.


This table compares Strata Skin Sciences and Unilife Corp’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Strata Skin Sciences -18.00% -41.58% -13.22%
Unilife Corp -654.23% N/A -78.00%

Analyst Ratings

This is a breakdown of recent ratings and price targets for Strata Skin Sciences and Unilife Corp, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Strata Skin Sciences 0 0 2 0 3.00
Unilife Corp 0 0 0 0 N/A

Strata Skin Sciences presently has a consensus target price of $12.00, indicating a potential upside of 674.19%. Given Strata Skin Sciences’ higher possible upside, equities analysts clearly believe Strata Skin Sciences is more favorable than Unilife Corp.

Institutional & Insider Ownership

94.5% of Strata Skin Sciences shares are owned by institutional investors. Comparatively, 14.9% of Unilife Corp shares are owned by institutional investors. 12.9% of Strata Skin Sciences shares are owned by insiders. Comparatively, 1.9% of Unilife Corp shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.


Strata Skin Sciences beats Unilife Corp on 8 of the 9 factors compared between the two stocks.

About Strata Skin Sciences

STRATA Skin Sciences, Inc., formerly MELA Sciences, Inc., is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging. The XTRAC and VTRAC products are the devices used for the treatment of psoriasis, vitiligo and other skin disorders. The XTRAC system delivers targeted ultraviolet light to affected areas of skin, leading to psoriasis clearing and vitiligo repigmentation, following a series of treatments. The Company’s technology includes XTRAC Excimer Laser, VTRAC Lamp and MelaFind. MelaFind is a non-invasive, point-of-care instrument to aid dermatologists in their decision to biopsy suspicious pigmented lesions, such as melanoma. The Company has approximately two distribution channels for phototherapy treatment equipment.

About Unilife Corp

Unilife Corp is engaged in the designing, development and manufacturing of injectable drug delivery systems. The Company has a portfolio of product platforms, including pre-filled syringes, disposable and reusable auto-injectors, drug reconstitution delivery systems, ocular delivery systems, and other systems for the targeted delivery of injectable therapies. The majority of its products are designed for sale directly to pharmaceutical and biotechnology companies supplying them as drug-device combination products, pre-filled and ready for administration by end-users, such as health-care providers or patients. Its other products, such as reusable auto-injectors and certain systems for targeted drug delivery are designed either to be sold to pharmaceutical or biotechnology companies for use as combination products or to be sold directly to a health care provider or end user without having the device pre-filled by a pharmaceutical company.

What are top analysts saying about Strata Skin Sciences Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Strata Skin Sciences Inc. and related companies.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit